Lincoln PharmaceuticalsLINCOLN 
0.76%24h
Lincoln Pharmaceuticals (LINCOLN) Stock Overview
Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India and internationally. The company provides products in the areas of cough and cold, anti-allergic, and anti-asthmatics; sterile ophthalmic eye drops and ointment; anti-malarial; vitamins, minerals, and antioxidants; anti-bacterial, anti-viral, and anti-fungal vitamins; analgesic and anti-pyretic; anti-psychotic, anti-convulsant, anti-depressant, and anti-diabetic; cardiac anti-hypertensives, and diuretic; and anti-diarrheal, anti-spasmodic, and laxative, as well as dermatologist preparations, gynecological products, gastrointestinal rang, otology products, and phosphodiesterase type 5 inhibitor and general anesthetics. It also offers branded generics. Lincoln Pharmaceuticals Limited was incorporated in 1979 and is based in Ahmedabad, India.
LINCOLN Stock Information
Lincoln Pharmaceuticals (LINCOLN) Price Chart
Lincoln Pharmaceuticals Overview: Key Details and Summary
Stock data | 2023 | Change |
|---|---|---|
| Price | $9.27 | N/A |
| Market Cap | $185.68M | N/A |
| Shares Outstanding | 20.03M | -0.00% |
| Employees | 1.65K | N/A |
| Shareholder Equity | 5.02B | 16.08% |
Valuation | 2023 | Change |
|---|---|---|
| P/E Ratio | 0.25 | N/A |
| P/S Ratio | 3.06 | N/A |
| P/B Ratio | 0.04 | N/A |
Growth | 2023 | Change |
|---|---|---|
| Return on Equity | 0.0017 | N/A |
Earnings | 2023 | Change |
|---|---|---|
| Revenue | $60.76M | N/A |
| Earnings | $8.68M | N/A |
| EPS | 36.40 | N/A |
| Earnings Yield | 3.93 | N/A |
| Gross Margin | 0.527 | N/A |
| Operating Margin | 0.1568 | N/A |
| Net income margin | 0.1429 | N/A |
Financial Strength | 2023 | Change |
|---|---|---|
| Total Assets | $69.95M | N/A |
| Cash on Hand | $15.04M | N/A |
| Debt to Equity | 0.0020 | -27.89% |
| Current Ratio | $5.08 | 30.28% |
